Herpes zoster – Diagnostics – Overview of Information and Clinical Research

Diagnosing herpes zoster, commonly known as shingles, typically involves examining the distinctive rash and learning about the patient’s symptoms. Healthcare providers look for specific patterns on the skin and may perform laboratory tests to confirm the diagnosis, especially when the presentation is unclear or complications are suspected. Early and accurate diagnosis is important because timely treatment can reduce the severity of symptoms and lower the risk of long-term complications like persistent nerve pain.

Introduction: When to Seek Diagnosis

Anyone who has had chickenpox in the past could potentially develop shingles later in life. The virus that causes chickenpox, called varicella-zoster virus or VZV, stays dormant in the nerve cells after chickenpox resolves and can reactivate years or even decades later, causing shingles.^[1]

You should consider seeking medical attention if you experience unusual pain, burning sensations, tingling, or sensitivity on one side of your body, especially if these symptoms are followed by a rash. Some people notice nerve pain, discoloration of the skin, or other warning signs weeks or even days before any visible rash appears. Because treatment works best when started early—ideally within 72 hours of the rash appearing—it’s important not to delay seeking care.^[1]^[2]

People over the age of 50 should be particularly vigilant, as shingles becomes more common with age and can lead to more severe complications in older adults. Those with weakened immune systems—such as individuals living with HIV, cancer patients, organ transplant recipients, or people taking medications that suppress the immune system—are also at higher risk and should seek diagnosis promptly if symptoms develop.^[3]^[4]

⚠️ Important

If shingles affects your eye area or you notice blisters on one side of your face near the eye, seek medical attention immediately. Eye involvement can lead to serious complications including vision loss if not treated promptly. Similarly, if you are pregnant, have a weakened immune system, or experience symptoms of shingles, you should see a healthcare provider as soon as possible.^[5]

Even if you don’t develop a rash, you should still see a doctor if you have symptoms that could indicate shingles. Some people experience what’s called “zoster sine eruptione,” meaning they have shingles pain without the characteristic rash. This can make diagnosis more challenging, but it’s still important to get evaluated.^[1]

Classic Diagnostic Methods

The diagnosis of herpes zoster is usually straightforward when the classic symptoms are present. Healthcare providers primarily rely on a combination of your medical history and a physical examination of the rash to make the diagnosis. This clinical approach is often sufficient and doesn’t always require laboratory testing.^[1]^[6]

Medical History and Physical Examination

During your visit, your healthcare provider will ask detailed questions about your symptoms. They’ll want to know when the pain or other sensory symptoms started, where you feel them, and whether you’ve had chickenpox in the past. Understanding the timeline is important because shingles symptoms typically progress in a predictable pattern—pain and tingling usually come first, followed by the rash a few days later.^[5]

The physical examination focuses on looking at the rash and its location on your body. Healthcare providers look for specific characteristics that distinguish shingles from other skin conditions. The most telling feature is the rash’s distribution along a dermatome—a strip of skin served by a single nerve. The rash typically appears on just one side of the body (unilateral) and doesn’t cross the midline, creating a stripe-like pattern that might wrap around the chest, back, or appear on one side of the face or neck.^[1]^[8]

The appearance of the rash itself provides important clues. Early in the infection, you might see patches of reddish or discolored skin that may feel tender or sensitive. Within a few days, these patches develop into groups of small, fluid-filled blisters that sit on a red base. These blisters are similar in appearance to those seen in chickenpox but are grouped together in clusters rather than scattered widely across the body.^[5]^[6]

Laboratory Testing

While most cases of shingles can be diagnosed without laboratory tests, your provider may order additional testing in certain situations. Lab tests are particularly useful when the diagnosis isn’t clear, when you don’t have the typical rash, when your immune system is compromised, or when complications are suspected.^[1]

One common laboratory method involves taking a sample from the blisters. Your healthcare provider may gently scrape the base of a blister or use a swab to collect fluid from the blisters. This sample is then sent to a laboratory where specialists can look for the varicella-zoster virus. The virus can be detected through various techniques, though the specific method used may vary depending on the laboratory.^[1]^[12]

In some cases, particularly when the presentation is atypical or the diagnosis is uncertain, healthcare providers might order blood tests. These tests can help confirm exposure to the varicella-zoster virus, though they’re not always necessary for routine diagnosis of shingles.^[7]

Distinguishing Shingles from Other Conditions

An important part of diagnosis involves making sure the symptoms are actually caused by shingles and not another condition. Several other skin problems can sometimes look similar to shingles, which is why the pattern and distribution of the rash are so important for accurate diagnosis.^[8]

The location and one-sided nature of the shingles rash help distinguish it from chickenpox, which spreads across the entire body rather than following a single nerve pathway. Other conditions that might be confused with shingles include certain types of skin infections, contact dermatitis (an allergic skin reaction), or other viral rashes. The characteristic pattern along a dermatome and the presence of severe, burning pain along that area are key features that help healthcare providers identify shingles correctly.^[16]

Diagnosing shingles can be more challenging in children and younger adults, particularly if the clinical presentation is mild or unusual. In these age groups, healthcare providers need to be especially careful to consider other possible causes of the symptoms before confirming a diagnosis of shingles.^[14]

Imaging and Special Circumstances

In most cases of shingles, imaging tests like X-rays, CT scans, or MRI scans are not needed for diagnosis. However, if there are concerns about complications—such as involvement of internal organs, the nervous system, or the eyes—additional diagnostic procedures may be necessary. For instance, if shingles affects the eye (called herpes zoster ophthalmicus), an eye specialist might perform detailed eye examinations to check for damage to the various structures of the eye.^[3]

Diagnostics for Clinical Trial Qualification

When patients with herpes zoster are being considered for participation in clinical trials, the diagnostic requirements may be more specific and stringent than those used in routine clinical practice. Clinical trials investigating new treatments for shingles or its complications need to ensure that all participants truly have the condition and meet specific criteria to make the study results valid and reliable.^[10]

For clinical trial enrollment, laboratory confirmation of varicella-zoster virus infection is often required, even if the clinical diagnosis seems clear. This typically involves collecting samples from the shingles blisters and testing them in specialized laboratories. The purpose of this requirement is to eliminate any possibility of misdiagnosis and to ensure that everyone in the study has the same confirmed condition.^[8]

Trials may also have specific requirements about the timing of diagnosis. For example, studies evaluating antiviral medications might only enroll patients who are diagnosed within a certain number of hours or days after the rash first appears. This is because the effectiveness of many treatments depends on how quickly they are started, so researchers need to control for this factor when measuring outcomes.^[10]^[11]

Additional diagnostic tests may be performed as part of trial screening to assess the severity of disease and ensure patient safety. These might include detailed assessments of pain levels using standardized scales, evaluation of the extent of the rash, checking for any signs of complications, and laboratory tests to assess overall health status. For trials involving patients at high risk for complications, such as those with weakened immune systems, additional blood tests might be required to measure immune function.^[13]

Age and medical history are important qualifying factors for many clinical trials. Some studies focus specifically on older adults (typically those over 50 or 60 years old) because this population is at higher risk for severe disease and complications like postherpetic neuralgia—persistent nerve pain that continues long after the rash heals. Other trials might focus on immunocompromised patients, such as those with cancer, HIV infection, or those taking immunosuppressive medications. In these cases, documentation of the underlying condition and recent laboratory results may be required.^[11]

⚠️ Important

Clinical trials often have strict exclusion criteria as well. Patients may be excluded if they have certain complications, have already started treatment, or have other health conditions that could interfere with the study. If you’re interested in participating in a clinical trial for shingles, your healthcare provider can help determine whether you might be eligible and explain what diagnostic tests would be involved in the screening process.

For studies examining prevention of postherpetic neuralgia, baseline pain assessments using validated measurement tools are critical. Researchers need to document the severity and characteristics of pain at the time of enrollment so they can accurately measure whether the intervention reduces the risk or severity of long-term pain. This might involve questionnaires, pain diaries, or other standardized assessment methods.^[13]

Some clinical trials also collect samples for research purposes beyond what’s needed for diagnosis. This might include extra blood samples to study immune responses, skin biopsies to understand tissue changes, or viral samples to study the characteristics of the virus. Participation in these additional research procedures is typically optional and would be explained as part of the informed consent process.^[8]

Prognosis and Survival Rate

Prognosis

The outlook for most people with herpes zoster is generally good, though the disease course and long-term outcomes can vary significantly depending on several factors. In uncomplicated cases, particularly in children and young adults, recovery is typically complete within two to three weeks. Older patients may take three to four weeks or longer to fully recover.^[3]

Age is one of the most important factors affecting prognosis. While shingles can occur at any age, it tends to be more benign and mild in children. In contrast, older adults—especially those over 50 years of age—are at higher risk for more severe symptoms, prolonged illness, and complications. The natural weakening of the immune system that occurs with aging is thought to be responsible for both the increased frequency and severity of shingles in older populations.^[8]^[14]

The immune status of the patient plays a critical role in determining outcomes. People with compromised immune systems—whether due to HIV infection, cancer, organ transplantation, or immunosuppressive medications—tend to have more severe disease, a higher risk of complications, and potentially slower recovery. These individuals may experience the spread of the virus to multiple dermatomes or even throughout the body (disseminated herpes zoster), which is a more serious condition.^[3]^[14]

The most common long-term complication is postherpetic neuralgia, which affects approximately 9 to 45 percent of all shingles cases depending on the study and population examined. This condition involves persistent or recurring pain that lasts 30 days or more after the acute infection resolves or after all lesions have crusted over. The pain can be severe enough to interfere with daily activities and quality of life. The risk of developing postherpetic neuralgia increases dramatically with age, occurring nearly 15 times more often in people over 50 compared to younger individuals.^[8]^[11]

Other complications that can affect prognosis include eye problems (which can lead to temporary or permanent vision loss), hearing or balance issues, facial muscle weakness, and rarely, more serious conditions like brain inflammation (encephalitis) or pneumonia. When shingles affects the eye area (herpes zoster ophthalmicus), about half of patients who receive appropriate treatment can expect complete recovery, with most others experiencing at least some improvement.^[3]^[16]

Early treatment with antiviral medications, particularly when started within 72 hours of rash onset, can improve outcomes by reducing the severity and duration of symptoms. While there is debate about whether antivirals prevent postherpetic neuralgia, some studies suggest that certain antiviral medications may shorten its duration if it does occur.^[13]

Recurrence of shingles is possible but relatively uncommon. Most people who develop shingles only experience one episode during their lifetime. However, recurrence rates are higher in people with weakened immune systems. Having one episode of shingles does not provide complete protection against future episodes.^[2]^[16]

Survival rate

Herpes zoster is rarely fatal in otherwise healthy individuals. Death from shingles is uncommon and typically only occurs in people with severely compromised immune systems or when serious complications develop, such as widespread disseminated disease, severe bacterial infections, or brain inflammation.^[1]^[12]

One study estimated that approximately 96 deaths occur annually in the United States from herpes zoster and its complications. Given that an estimated one million cases of shingles occur each year in the United States, this represents a very low fatality rate. The vast majority of these deaths occur in elderly patients or those with significant underlying health conditions.^[14]

The risk of hospitalization due to shingles increases with age and immunosuppression. About 30 percent of people hospitalized with herpes zoster have compromised or suppressed immune systems. While hospitalization may be necessary for managing severe symptoms or complications, most patients recover with appropriate treatment.^[8]

For pregnant women who are otherwise healthy, herpes zoster is generally not associated with severe outcomes for the mother or baby. Unlike chickenpox in pregnancy, shingles does not appear to cause congenital problems, miscarriage, or premature delivery when it occurs during pregnancy.^[16]

#1 Clinical Trials Search in Europe

Herpes zoster – Diagnostics

Introduction: When to Seek Diagnosis